Loading…
Loading…
MUMBAI, India--(BUSINESS WIRE)--To support India's growing international connectivity demands, FLAG, previously known as GCX, is leveraging Ciena's (NYSE: CIEN) WaveLogic 6 Extreme (WL6e) across two segments of its India Connectivity Mesh, Chennai-Singapore and Mumbai-Singapore. FLAG is using Ciena's GeoMesh Extreme solution, powered by WL6e, to upgrade capacity on these segments to transport 400GbE client services and, in the near future, 800GbE client services. “In today's hyper-connected wor.
For many of us, ETFs have been synonymous with passive management. Since the early 1990s, ETFs have followed in the footsteps of the most well-known passive ETF — the S&P 500 ETF Trust (SPY).
It's early days into the earnings season, and FactSet data shows that results reported so far put the S&P 500 on track for its seventh consecutive quarter of growth. The S&P 500, however, is sitting at about a 10% loss year-to-date, struggling to find a lot of upside amid ongoing concerns about international trade.
Global X introduces two new U.S. equity ETFs today on the NYSE – the Global X S&P 500 U.S. Revenue Leaders ETF (EGLE), and the Global X S&P 500 U.S Market Leaders Top 50 ETF (FLAG).
Business combination transaction with First Light Acquisition Group, a special purpose acquisition company, completed on September 12, 2023
Business combination transaction with Calidi Biotherapeutics anticipated to be completed on September 12, 2023 Gross proceeds made available to Calidi Biotherapeutics from transaction will total approximately $28 million, including funds held in First Light Acquisition Group's trust account before deducting transaction expenses and debt repayments In addition, Calidi secured a forward purchase agreement for up to $10 million with a consortium including Meteora Capital LLC, Great Point Capital LLC, and Funicular Funds, LP Listed company to be named Calidi Biotherapeutics, Inc. Common stock and warrants approved for listing on the New York Stock Exchange American under the ticker symbols “CLDI” and “CLDI WS,” respectively; expected to begin trading on September 13, 2023 NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- First Light Acquisition Group, Inc. (NYSE: FLAG) (“FLAG”) today announced that it anticipates completing its business combination with Calidi Biotherapeutics on September 12, 2023.
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- First Light Acquisition Group, Inc. (NYSE: FLAG) (“FLAG”) today announced that it reconvened and then further adjourned, without conducting any other business, its virtual Special Meeting of Stockholders to August 28, 2023 at 10:30 a.m., Eastern time (the “Special Meeting”). The Special Meeting was previously convened and adjourned on August 22, 2023.
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- First Light Acquisition Group, Inc. (NYSE: FLAG) (“FLAG”) today announced that it convened and then adjourned, without conducting any other business, its virtual Special Meeting of Stockholders to August 24, 2023 at 10:30 a.m., Eastern time (the “Special Meeting”). The adjourned Special Meeting will be held via the same live webcast at https://www.cstproxy.com/firstlightacquisition/2023.